Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer

British Journal of Cancer

Volumn 78, Issue 2, 1998, Pages 205-209

  Losch A ^a,b   Tempfer, C ^a   Kohlberger, P ^a   Joura, E A ^a   Denk, M ^a   Zajic, B ^a   Breitenecker, G ^a   Kainz, C ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Breast; Cathepsin D; Neoplasm; Prognosis

Indexed keywords

CATHEPSIN D; ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; BREAST DUCT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MORPHOLOGY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031841785     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.465     Document Type: Article

References (24)

1. 1, breast carcinoma. Am J Surg Pathol 18: 158-166
2. Cardiff RD (1994) Cathepsin D and breast cancer: useful? Hum Pathol 25: 847-848
3. Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc 34: 187-209
4. Dawson PJ (1993) What is new in the understanding of multifocal breast cancer? Pathol Res Pract 189: 111-116
5. Domagala W, Striker G, Szadowska A, Dukowicz A, Weber K and Osborn M (1992) Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years. Am J Pathol 141: 1003-1012
6. Gohring UJ, Scharl A, Thelen U, Ahr A, Crombach G and Titius BR (1996) Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods. J Clin Pathol 49: 57-64
7. Henry JA, McCarthy AL, Angus B, Westley BR, May FEB, Nicolson S, Cairns J, Harris AL and Horne CHW (1990) Prognostic significance of the estrogen-regulated protein cathepsin D in breast cancer. Cancer 65: 265-271
8. Isola J, Weitz S, Visakorpi T, Holli K, Shea R, Khabbaz N and Kallioniemi OP (1993) Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J Clin Oncol 11: 36-43
9. Joensuu H, Toikkanen S and Isola J (1995) Stromal cell cathepsin D expression and long-term survival in breast cancer. Br J Cancer 71: 155-159
10. Kandalaft PL, Chang KL, Ahn CW, Traweek ST, Metha P and Battifora H (1993) Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer. Cancer 71: 2756-2763
11. Kaplan EL and Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-458
12. Nadji M, Fresno M, Nassiri M, Conner G, Herrero A and Morales AR (1996) Cathepsin D in host stromal cells, but not in tumor cells, is associated with behavior in node-negative breast cancer. Hum Pathol 9: 869-871
13. O'Donoghue AEMA, Poller DN, Bell JA, Galea MH, Elston CW, Blamey RW and Ellis IO (1995) Cathepsin D in primary breast carcinoma: adverse prognosis associated with expression of cathepsin D in stromal cells. Breast Cancer Res Trends 33: 137-145
14. Rochefort H (1996) The prognostic value of cathepsin D in breast cancer. A long road to the clinic. Eur J Cancer 32A: 7-8
15. Rochefort H, Capony F and Garcia M (1987) Estrogen induced lysosomal protease secreted by breast cancer cells: a role in carcinogenesis? J Cell Biochem 34: 17-29
16. Schnitt SJ, Connolly JL, Harris JR, Hellman S and Cohen RB (1984) Pathologic predictors of early local recurrency in stage I and II breast cancer treated by primary radiation therapy. Cancer 53: 1049-1057
17. Silverberg SG and Chitale AR (1973) Assessment of significance of proportions of intraductal and infiltrating tumour growth in ductal carcinoma of the breast. Cancer 32: 830-837
18. Spyratros F, Maudelonde T, Brouillet JP, Brunet M, Defrenne A, Andrieu C, Hacene K, Desplaces A, Rouesse J and Rochefort H (1989) Cathepsin D: an independent prognostic factor for metastasis of the breast. Lancet 2: 1115-1118
19. Tandon AK, Clarke GM, Chamness GC, Chirgwin JM and McGuire (1990) Cathepsin D and prognosis in breast cancer. N Engl J Med 322: 297-302
20. Tavassoli FA (1992) Pathology of the breast. General Considerations: Multicentricity, pp. 49-50. Appleton Lange: Norwalk. CT
21. Tetu B, Brisson J, Cote C, Brisson S, Potvin D and Roberger N (1993) Prognostic significance of cathepsin D expression in node-positive breast carcinoma: an immunohistochemical study. Int J Cancer 55: 429-435
22. Thorpe SM, Rochefort H, Garcia M, Freiss G, Christensen IJ, Khalaf S, Paolucci F, Pau B, Rasmussen BB and Rose C (1989) Association between high concentration of M, 52,000 cathepsin D and poor prognosis in primary breast cancer. Cancer Res 49: 6008-6014
23. Westley BR and May FEB (1996) Cathepsin D and breast cancer. Eur J Cancer 32A: 15-24
24. Winstanley JHR, Leinster SJ, Cooke TG, Westley BR, Platt-Higgins AM and Rudland PS (1993) Prognostic significance of cathepsin D in patients with breast cancer. Br J Cancer 67: 767-772